The Silberstein Lab, part of the Stem Cell and Gene Therapy Program at Fred Hutch, investigates the regulation of hematopoietic stem cell self-renewal by extrinsic factors. We aim to develop therapeutic approaches to enhance blood cell production for patients with myelodysplasia, inherited bone marrow failure and those recovering from transplantation.